Suppl. Fig.1Matsuyama
c
Bax (1g)+Ku80
0
20
40
60
80
Contro
l
Ku80+Vect
or0.5
g1.0
g2.0
g
Bax+Vect
or
Apo
ptos
is (%
)
Ku80
-Tubulin
Contro
l
Ku80
Ku70
-Tubulin
Ku80
Contro
l 0.
5g
1.0
g 2.
0g
Ku70wtb
a
Bax+Ku70
100 101 102 103 104FL2-H
M1
15.25%
020
0C
ount
s
Bax+z-VAD
100 101 102 103 104FL2-H
M1
020
0C
ount
s
16.49%
No PI
Contro
l
Bax Bax+Ku70
Bax+z-V
AD
020
0C
ount
s
Control
100 101 102 103 104FL2-H
M1
8.78%Bax
100 101 102 103 104FL2-H
M1
43.75%
020
0C
ount
s
020
0C
ount
sNo PI
100 101 102 103 104FL2-H
M1
0%
1. NRS2. Anti-Bax3. Mouse IgG4. Anti-Ku705. Molecular Marker6. NRS7. Anti-Bax8. Mouse IgG9. Anti-Ku70
Input
IP
IP
4131
187
1 2 3 4 5 6 720012785
Ku70
a
NS
NS
4131
187
1 2 3 4 5 6 720012785
Ku70
c
NS
NS
1 2 3 4 5 8 9
17
202121
31
79
41
8
Bax
NSNS
d
b
Bax
1 2 3 4 5 8 9200127854131
18
7
Suppl. Fig.2Matsuyama
1. NRS2. Anti-Ku703. Mouse IgG4. Anti-Bax5. Molecular Marker6. Mouse IgG7. Anti-Bax8. NRS9. Anti-Ku70
Input
IP
IP
200127 85 41 31
18 7
1 2 3 4 5 8 9
Bax
b200127 85
41 31
18 7
1 2 3 4 5 6 7
Ku70
a
NS
c200127 85
41 31
18 7
1 2 3 4 5 6 7
Ku70
NS
NS
NS
d200127 85 41 31 18 7
1 2 3 4 5 8 9
Bax
NS NS
Suppl. Fig.3Matsuyama
NRS A
nti-Ku70
Anti-
Bax
NRSAnti-
Ku70
Anti-
Bax
Input
Input
IP
Ku70 Ku70
Ku70
Bax
Bax
Bax
CytosolNRS
Anti-
Ku70
Anti-
Bax
NRS A
nti-Ku70
Anti-
Bax
Input
Input
IP
Ku70 Ku70
Ku70
Bax
Bax
Bax
Total
e
a- + - + - + - +z-VAD
- -+ +- +
STSAlkali
Bax
F1
Suppl. Fig.4
74k
32k
GFP
GFP-Bax
wt
GFP-B
ax N
GFP-Bax
P13A
Input (GFP-Bax)
Input(Ku70)
IP
Ku70
Ku70
cb
0
10
20
30
40
50
Contro
lBax
+Vector
Bax+Ku70
Bax P13
A+Vect
orBax
P13A
+Ku70
Apo
ptos
is (%
)d
-Tubulin
0 3 6 12 24UV treatment time (h)
85
4131
187
200127
Ku70
fNo t
reatm
ent
UV No trea
tmen
t
UV+z-VAD
STSSTS+z-V
AD
116kDa
85kDa
-Tubulin
PARP
Matsuyama
Control
STSSTS+z-V
AD
85
4131
187
200127
Ku70
e
Top Related